ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GNPX Genprex Inc

2.24
0.03 (1.36%)
May 24 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Genprex Inc GNPX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 1.36% 2.24 23:00:05
Open Price Low Price High Price Close Price Previous Close
2.22 2.1957 2.34 2.20 2.21
more quote information »

Recent News

Date Time Source Heading
5/20/202415:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/15/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202407:31PRNUSGenprex Doses First Patient in Acclaim-3 Clinical Study of..
5/13/202407:31PRNUSGenprex Announces the Appointment of Jose A. Moreno Toscano..
5/09/202407:11EDGAR2Form 8-K - Current report
5/08/202417:08PRNUSGenprex Announces the Passing of its Co-Founder and Chief..
5/01/202407:31PRNUSGenprex to Present and Participate at Upcoming May Investor..
4/09/202407:31PRNUSGenprex Collaborators Report Positive Preclinical Data on..
4/03/202407:31PRNUSGenprex Expands Clinical Trial Sites for Acclaim-3 Clinical..
4/02/202407:31PRNUSGenprex Collaborators Publish Positive Preclinical Data with..
3/22/202415:10PRNUSGenprex Announces Closing of $6.5 Million Registered Direct..
3/19/202412:24PRNUSGenprex Announces $6.5 Million Registered Direct Offering..
3/19/202407:36PRNUSGenprex Announces $6.5 Million Registered Direct Offering..
3/12/202408:01PRNUSGenprex Receives Notice of Patent Grant for Korean Patent..
3/06/202408:18EDGAR2Form 8-K - Current report
3/06/202407:30PRNUSGenprex Collaborators to Present Positive Preclinical Data..
2/26/202407:45EDGAR2Form 8-K - Current report
2/21/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202413:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202407:15PRNUSGenprex Expands Nonclinical Programs into New Therapeutic..
2/06/202406:30PRNUSGenprex to Present at Upcoming BIO CEO & Investor Conference
2/05/202407:15EDGAR2Form 8-K - Current report
2/05/202406:30PRNUSGenprex Announces First Patient Dosed in Phase 2a Expansion..
2/02/202406:30EDGAR2Form 8-K - Current report
1/31/202408:00EDGAR2Form 8-K - Current report
1/31/202407:42PRNUSGenprex Announces 1-for-40 Reverse Stock Split Effective..
1/05/202415:17EDGAR2Form 8-K - Current report
1/05/202406:00PRNUSGenprex Provides Business Update and Outlook for 2024
12/18/202315:35EDGAR2Form 8-K - Current report
12/13/202315:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/13/202315:44EDGAR2Form 8-K - Current report
11/14/202310:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202315:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/03/202315:16EDGAR2Form DEF 14A - Other definitive proxy statements
11/01/202306:30PRNUSGenprex to Present at BIO-Europe 2023 Conference
10/23/202316:01EDGAR2Form PRE 14A - Other preliminary proxy statements
10/23/202315:44EDGAR2Form 8-K - Current report
10/20/202306:30PRNUSGenprex to Host a Virtual Key Opinion Leader Event on..
10/04/202311:00PRNUSGenprex to Present Data on the Use of REQORSA® for the..
9/25/202315:20EDGAR2Form 8-K - Current report
9/21/202307:30GLOBEGenprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation..
9/20/202307:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
9/08/202315:20EDGAR2Form 8-K - Current report
9/07/202306:30PRNUSGenprex to Present at Upcoming September Investor Conference
9/01/202315:17EDGAR2Form 8-K - Current report
8/22/202306:30PRNUSGenprex Appoints Suzanne Thornton-Jones as Senior Vice..
8/21/202316:13EDGAR2Form 8-K/A - Current report: [Amend]
8/21/202311:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

Delayed Upgrade Clock